Emerging Oral Therapies for Multiple Sclerosis

被引：1
|
作者：
Miller, Colleen E. [1 ]
Umhauer, Margaret A. [1 ]
机构：
[1] SUNY Buffalo, William C Baird Multiple Sclerosis Res Ctr, Jacobs Neurol Inst, Buffalo, NY 14260 USA
来源：
JOURNAL OF NEUROSCIENCE NURSING | 2011年 / 43卷 / 01期
关键词：
NOVO RENAL-TRANSPLANTATION; PLACEBO-CONTROLLED TRIAL; FUMARIC-ACID ESTERS; DOUBLE-BLIND; FINGOLIMOD FTY720; PHASE-II; MULTICENTER; CLADRIBINE; LAQUINIMOD; TERIFLUNOMIDE;
D O I：
10.1097/JNN.0b013e31820297a9
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Despite notable advances in the understanding of multiple sclerosis (MS) and the availability of several treatment options, there is a need for therapies that are more effective, safe, convenient, and well tolerated. Several new oral MS therapies are being investigated. Because data on these new therapies continue to emerge, nurses will play a pivotal role in educating patients regarding the benefits and risks of potential treatments and in monitoring patients for response, safety, tolerability, and adherence. This article reviews the oral MS therapies recently approved as well as those currently in development or submitted for Food and Drug Administration approval.
引用
收藏
页码：3 / 14
页数：12
相关论文
共 50 条
  • [1] Emerging multiple sclerosis oral therapies
    Rammohan, Kottil W.
    Shoemaker, Jennifer
    [J]. NEUROLOGY, 2010, 74 (01) : S47 - S53
  • [2] Emerging oral therapies for multiple sclerosis
    Cohen, B. A.
    Rieckmann, P.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (11) : 1922 - 1930
  • [3] Emerging Oral Therapies in Multiple Sclerosis
    Devon Conway
    Jeffrey A. Cohen
    [J]. Current Neurology and Neuroscience Reports, 2010, 10 : 381 - 388
  • [4] Emerging Oral Therapies in Multiple Sclerosis
    Conway, Devon
    Cohen, Jeffrey A.
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2010, 10 (05) : 381 - 388
  • [5] Emerging disease-modifying oral therapies for multiple sclerosis
    Losy, Jacek
    Kalinowska-Lyszczarz, Alicja
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2011, 231 (1-2) : 15 - 22
  • [6] Emerging therapies for multiple sclerosis
    Paolo A. Muraro
    Bibiana Bielekova
    [J]. Neurotherapeutics, 2007, 4 : 676 - 692
  • [7] Emerging therapies for multiple sclerosis
    de Lorenzo-Pinto, Ana
    Guadalupe Rodriguez-Gonzalez, Carmen
    Ais-Larisgoitia, Arantza
    [J]. MEDICINA CLINICA, 2013, 140 (02): : 76 - 82
  • [8] Emerging therapies for multiple sclerosis
    Muraro, Paolo A.
    Bielekova, Bibiana
    [J]. NEUROTHERAPEUTICS, 2007, 4 (04) : 676 - 692
  • [9] Emerging therapies for multiple sclerosis
    WeinstockGuttman, B
    Cohen, JA
    [J]. NEUROLOGIST, 1996, 2 (06) : 342 - 355
  • [10] Currently approved and emerging oral therapies in multiple sclerosis: An update for the ophthalmologist
    Eckstein, Christopher
    Bhatti, M. Tariq
    [J]. SURVEY OF OPHTHALMOLOGY, 2016, 61 (03) : 318 - 332
12345